• Biotinylated Human EGFRVIII on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.
  • The purity of Biotinylated Human EGFRVIII is greater than 95% as determined by SEC-HPLC.
  • Immobilized Biotinylated Human EGFRVIII, His Tag at 0. 5 Mu g/ml (100 Mu l/Well) on the plate. Dose response curve for Anti-EGFRVIII Antibody, hFc Tag with the EC50 of 16. 1ng/ml determined by ELISA.

Human EGFRVIII protein (Recombinant) (C-His-Avi) {Biotin} (STJP001704)

SKU:
STJP001704

Shipping:
Free Shipping
Current Stock:
Host: HEK293
Note: STRICTLY FOR FURTHER RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Recombinant-Human EGFRVIII-C-His-Avi protein was developed from hek293 and has a target region of C-His-Avi. For use in research applications.
Conjugation: Biotin
Formulation: Lyophilised from 0.2 µm filtered PBS solution pH7.4.
Dilution Range: Upon receipt centrifuge vial to ensure maximal product extraction, recommended: 20sec, 5K RPM
Storage Instruction: The lyophilized protein is stable for at least 1 year from date of receipt at-20°C.
Endotoxin: Endotoxin content was assayed using a LAL gel clot method. Endotoxin level was found to be less than 0.1 ng/µg (1EU/µg).
Immunogen Region: Leu25-Ser378
Immunogen: DNA sequence encoding Human EGFRVIII including a C-His-Avi tag was expressed in HEK293 Cells. The recombinant protein was then biotinylated site specific using the AVItag biotinylation technology.
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance